Entry Instance

HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 828770,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/828770/?format=api",
    "text_counter": 1373,
    "type": "speech",
    "speaker_name": "Murang’a CWR, JP",
    "speaker_title": "Hon. (Ms.) Sabina Chege",
    "speaker": {
        "id": 884,
        "legal_name": "Sabina Wanjiru Chege",
        "slug": "sabina-wanjiru-chege"
    },
    "content": " Hon. Temporary Deputy Chairman, I beg to move: THAT, the Schedule to the Bill be amended – (i) by inserting the following new amendment immediately after the proposed new section 9F− New Insert the following new section immediately after section 12− section Enquiries and 12A. (1) The Board shall establish an Enquiries and Disciplinary Disciplinary Committee which shall enquire into any matter arising under Committee. section 12 of this Act. (2) Where on the recommendations of the Enquiries and Disciplinary Committee the Board is satisfied that a pharmacist or pharmaceutical technologist is in breach of any of the terms or conditions of practice prescribed by the Board, the Board may− (a) issue the pharmacist or pharmaceutical technologist with a letter of admonishment; (b) impose a fine as may be prescribed in regulations; (c) suspend the registration or enrolment of the pharmacist or pharmaceutical technologist for a specified period not exceeding five years; or (d) remove the name of the pharmacist or pharmaceutical technologist from the Register as may be appropriate. (3) The Board may order a pharmacist or pharmaceutical technologist to reimburse costs and expenses incurred in connection with a disciplinary hearing and such The electronic version of the Official Hansard Report is for information purposes only. Acertified version of this Report can be obtained from the Hansard Editor."
}